Literature DB >> 20415285

Live or Let Die: Epithelial Flap Vitality and Keratocyte Proliferation Following LASEK and Epi-LASIK in Human Donor and Porcine Eyes.

Romesh I Angunawela, Christoph Winkler von Mohrenfels, Anupma Kumar, David P S O'Brart, John Marshall.   

Abstract

PURPOSE: To determine the relationship between epithelial flap vitality and stromal keratocyte proliferation following two epithelial refractive techniques: epi-LASIK and laser epithelial keratomileusis (LASEK).
METHODS: Human corneas were maintained in organ culture and underwent standard -6.00-diopter ablation. Rates of stromal keratocyte proliferation were detected 1 week postoperative using a Ki67 antibody specific to proliferating cells. Images were captured with a laser scanning confocal microscope and analyzed by a masked observer. Epithelial flap vitality was determined with propidium iodide using fresh porcine corneas. Epithelial flaps were created with Gebauer Epikeratome epi-LASIK or alcohol-assisted LASEK method. Flaps treated with 100% alcohol and uninjured corneas were used as controls.
RESULTS: The number of proliferating keratocytes was greatest at 1 week in the epi-LASIK corneas (P<.001). Cell vitality was greatest in the epi-LASIK flaps and declined in the LASEK and 100% alcohol flaps (P<.001).
CONCLUSIONS: In this in vitro setting, epi-LASIK results in an epithelial flap with significantly more live cells. There is also a greater number of proliferating stromal cells following epi-LASIK at 1 week. Based on these in vitro observations, epi-LASIK may result in greater levels of haze compared to LASEK. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Year:  2010        PMID: 20415285     DOI: 10.3928/1081597X-20100330-01

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  1 in total

1.  Photorefractive keratectomy in the correction of astigmatism using Schwind Amaris 750s laser.

Authors:  Okkes Baz; Necip Kara; Ercument Bozkurt; Engin Bilge Ozgurhan; Alper Agca; Kemal Yuksel; Yavuz Ozpinar; Ahmet Demirok
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.